Episode 145: The Truth About Peptides: Science, Regulation & the Unknown– Dr. Jess Beal-Stahl

The ALL ME® Podcast

The Truth About Peptides: Science, Regulation & the Unknown– Dr. Jess Beal-Stahl

Peptides are everywhere right now.

From social media influencers and wellness clinics to athletes and online marketplaces, peptides are being promoted as potential solutions for everything from recovery and muscle growth to longevity and overall wellness. But what exactly are peptides? Which ones are legitimate medications? What does "compounded" actually mean? And how much do we really know about the products being sold online?

In this episode of the ALL ME Podcast, we sit down with Dr. Jess Beal-Stahl, PharmD, a clinical sports pharmacist, compounding pharmacist, and nationally and internationally competitive weightlifter, to break down the rapidly changing world of peptides.

Dr. Beal-Stahl brings a unique perspective to the conversation, working directly with patients, athletes, and healthcare providers while also operating a compounding pharmacy. Together, we take a closer look at the science, regulation, gray market, social media influence, and unanswered questions surrounding peptides.

Disclaimer: This podcast is intended for educational and informational purposes only and is not a substitute for medical advice, diagnosis or treatment. Always consult a qualified healthcare professional regarding medications, peptides, supplements or other health-related decisions.

In This Episode, We Discuss:

• What exactly are peptides? Why the word "peptide" doesn't automatically mean something is safe or dangerous.
• FDA-approved peptide medications and why products such as insulin and GLP-1 medications are very different from experimental peptides being promoted online.
• Compounded medications: What a compounding pharmacy is, why compounding exists, and what it does-and does not-mean when it comes to safety and FDA approval.
• Research-grade peptides: What "research use only" actually means and why a product labeled for research is not intended for human consumption.
• BPC-157, TB-500 and other popular peptides: How much human research actually exists and why having "research" on a substance isn't the same as having strong clinical evidence that it is safe and effective.
• The current regulatory landscape: What the FDA Pharmacy Compounding Advisory Committee's recent recommendations mean and, importantly, what they do not mean.
• The gray market: Where consumers are finding peptides outside the traditional medical supply chain and why product quality, purity, sterility, storage and labeling can all become concerns.
• What's actually in the vial? Why online certificates of analysis and professional-looking websites don't necessarily provide the same safeguards as a regulated medication supply chain.
• DIY peptide preparation: The risks of asking consumers to calculate doses, reconstitute products, select diluents, determine stability and manage sterile injections themselves.
• The rise of "injection culture": How social media, wellness trends and the normalization of injectable treatments may be changing the way people perceive injections.
• Peptides and young people: Why the lack of research is particularly important when considering adolescents and developing bodies.
• The "quick fix" mentality: Why the rapid growth of peptide culture fits into a larger cultural desire for faster solutions to appearance, performance, recovery and wellness.
• The future of peptide medicine: Why peptides may ultimately play an important role in medicine while also requiring more research, clinical evidence and long-term data.

Chapters:

00:00 Introduction to the episode and guest

00:58 Dr. Jess Beal-Stahl's background and expertise

01:46 The intersection of sports, pharmacy, and peptides

02:54 What is a compounding pharmacy and its role

04:08 Differences between FDA-approved, compounded, and research peptides

05:05 Regulatory landscape and recent changes for peptides

06:55 Risks and safety concerns of peptides from the gray market

08:55 Safety data and clinical evidence for peptides like BPC 157

10:46 The impact of social media and injection culture

12:51 Legal considerations and the future of peptide regulation

14:55 Advice for consumers and healthcare providers

16:56 The importance of foundational health practices

19:01 The risks of the gray market and overseas sourcing

21:03 The role of the FDA and recent regulatory hearings

22:49 Long-term safety and efficacy concerns

25:02 The future of peptide therapies and research

26:52 Practical advice for those considering peptides

28:59 The importance of informed decision-making

30:51 Closing thoughts and key takeaways

Resources

https://www.theathletespharmacist.com/

https://www.instagram.com/jessb_rx/

Follow Us:

Twitter: @theTHF

Instagram: @theTHF

Facebook: Taylor Hooton Foundation

#ALLMEPEDFREE

Contact Us: 

Twitter: @theTHF

Instagram: @theTHF

Facebook: Taylor Hooton Foundation

#ALLMEPEDFREE

Email:  [email protected]

Phone: [phone]

ALL ME Assembly Programs: http://taylorhooton.org/education-resources/face-to-face-programs/